Gralise (Gabapentin Tablets): Latest Use, Abuse and Addiction News

Gabapentin, sold under names like Gralise, Horizant, and Neurontin, has become a popular choice for treating nerve pain, partial seizures, and shingles-related discomfort. Initially viewed as a safer alternative to opioids during the opioid crisis, its growing use has revealed some unexpected and worrying trends. Both medical professionals and law enforcement are now raising concerns…

Gabapentin Abuse and Addiction – Latest News

Table of Contents The Potential of Abuse of Gabapentin, a Nerve Pain Drug Resources and References: Ciera Smith, 22, started abusing drugs when she was 18, lured by the “good time” she and her pals found in smoking weed. She then turned to addictive painkillers later to anti-anxiety medications like Xanax and eventually Suboxone, a…

Focalin Use, Addiction and Withdrawal

Focalin is a brand name for a medication called dexmethylphenidate, which is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults. It belongs to a class of drugs known as central nervous system stimulants. Focalin works by increasing the levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which…

Fiorinal Side Effects, Addiction, Withdrawal

Individuals who suffer from tension-type headaches, which aren’t alleviated by over-the-counter (OTC) medications, may find help with combination drugs that include butalbital. Fiorinal, a medication commonly prescribed for tension and migraine headaches, contains a combination of aspirin, butalbital, and caffeine. While effective in alleviating pain for many individuals, Fiorinal also carries the risk of abuse…

Fioricet Abuse and Addiction – Latest News

In the realm of prescription medication, Fioricet stands out as a commonly prescribed treatment for tension headaches—a debilitating condition that affects millions worldwide. Comprising a combination of butalbital, a barbiturate; acetaminophen, a pain reliever and fever reducer; and caffeine, a central nervous system stimulant, Fioricet is designed to alleviate the symptoms of tension headaches by…

Fentanyl Patches Use, Abuse and Addiction

Fentanyl Transdermal is between 50 and 100 times more potent than morphine, from which it is derived. Although it can be injected or ingested orally (via a lollipop or lozenge), a standard ingestion method is to take the medication transdermally through patches. Duragesic is the most known brand name for fentanyl patches. Fentanyl abuse, including…

Exalgo Abuse and Addiction – Latest News

Perrigo will be adding to its portfolio of opioid generics. The FDA has approved Exalgo (hydromorphone HCL, 32 mg) extended-release tablets, another of the company’s generics. The drug is an opioid that is intended to manage moderate to severe pain in patients requiring continuous, around-the-clock pain opioid analgesia for an extended period. Perrigo said that…

Evekeo Abuse and Addiction – Latest News

Table of Contents Evekeo Addiction Effects Common side effects Serious side effects Risks Resources and References: The active component in Evekeo is amphetamine sulfate. It is a white, crystalline substance and a sympathomimetic amine of the amphetamine group. The CNS stimulant is a prescription drug and is considered a controlled substance. It can lead to addiction and…

EMSAM Patches Uses, Side Effects and Withdrawal

EMSAM is a prescription medication used to treat major depressive disorder. It belongs to a class of medications called monoamine oxidase inhibitors (MAOIs). EMSAM works by blocking the enzyme monoamine oxidase, which breaks down neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. By inhibiting this enzyme, EMSAM increases the levels of these neurotransmitters,…

EMBEDA® Extended-Release Capsules CII: Latest Use, Abuse and Addiction News

FDA has approved updated labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules, for oral consumption, CII, to incorporate abuse-deterrence studies. The updated label says EMBEDA has characteristics expected to mitigate abuse via the oral and intranasal (i.e., snorting) routes when crushed. However, the misuse of EMBEDA by these routes is still a possibility.…